Leverage our lentivirus production expertise to your advantage
From master cell bank production and expansion through to manufacture, we support you with the latest technologies from a state-of-the-art facility dedicated to the aseptic production of lentiviral vectors, helping you deliver life-changing therapeutics to patients.
Lentivirus Production Expertise
Greater consistency and reliability
Our GMP lentiviral vector production expertise highlights the expansive knowledge and technical talent of our team. This, combined with expertise in lentiviral transduction, available and scalable capacity, ensures we can accelerate your journey from bench-to-clinic and maintain reliable supply throughout.
Ensuring high product throughput and efficiency, our lentiviral vector production platform utilizes single-use technology and optimized closed and semi-automated processes to deliver larger batches with greater consistency and reliability.
Simplifying and de-risking your development and scale-up
We deliver a full suite of complementary process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research-grade and preclinical vector production, and analytical assay development and validation from the site.
Analytical testing services, including Recombinant Competent Lentivirus (RCL) testing, vector stability testing, and safety and sterility testing, are also available.
Lentiviral Vector Production Platforms
- Adherent lentiviral transduction
- Suspension lentiviral transduction
Scalable and Consistent Manufacturing
- Roller bottles, cell stacks and fixed-bed bioreactor
- Proprietary suspension 293T cell line for up to 200L production
- Single-use/closed systems for virus harvest, purification and concentration
- Access to cGMP compliant master cell banks for common cell lines including HEK293T
Retroviral Vector Production
We can initiate and maintain reliable supply for your early-phase clinical trials and beyond, delivering high-quality, cost-effective and precise GMP master cell bank retroviral vector production and host cell expansion via producer cell lines.
Looking for something else?
Viral Vector Process Development
We support you in developing robust, scalable, and efficient processes to help you realize the potential of your therapy.Read more
Cell Therapy Manufacturing
Leverage our world-class partnerships, streamline your production, and advance your cell therapy to trial and beyond.Read more